Table 1.
Distribution of STOML2 expression in cervical cancer patients according to clinicopathologic characteristics
Charecrestic | No. | STOML2 | P | |
---|---|---|---|---|
| ||||
+ | - | |||
Age (y) | 0.762 | |||
≤ 40 | 44 | 26 | 18 | |
> 40 | 50 | 28 | 22 | |
FIGO Stage | 0.013 | |||
IB | 62 | 30 | 32 | |
> IB | 32 | 24 | 8 | |
Tumor size | 0.025 | |||
≤ 4 cm | 57 | 38 | 19 | |
> 4 cm | 37 | 16 | 21 | |
Differentiation | 0.356 | |||
Grade 1/2 | 38 | 24 | 14 | |
Grade 3 | 56 | 30 | 26 | |
LN Metastasis | 0.808 | |||
No | 73 | 41 | 32 | |
Yes | 21 | 13 | 9 | |
Total NO. of patients | 94 | 54 | 40 |